# DESCRIPTION

## STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT

## BACKGROUND

## SUMMARY

## DETAILED DESCRIPTION

### Terms and Concepts

### Drug Design and Discovery

### Computational Methods

### In Vitro and In Vivo Methods

### Computer Systems

## EXAMPLES

### Example 1: Materials and Methods

### Example 2: Engineering Human PD-1 Loop Variants with Enhanced PD-L2 Affinity

### Example 3: PD-1 Loop Variants Showed Increased Binding Affinity and Association Kinetics for PD-L2 and PD-L1

### Example 4: X-Ray Crystal Structure of the Human PD-1/PD-L2 Complex

### Example 5: X-Ray Crystal Structures of Human Apo-PD-1 Loop Variants

### Example 6: Formation of a Prominent Pocket in Human PD-1 Upon Binding PD-L2, with Human PD-1 Pocket Having Architecture Distinct from that of Murine PD-1 Pocket

### Example 7: The CCâ€² Loop in the Triple-Mutant PD-1 Adopts a Ligand-Bound Conformation in the Absence of Ligand

### Example 8: Structural plasticity of the human PD-1 ligand-binding interface

### Example 9: Coordinates and Structure Factors

